Integrated care van delivery of evidence‐based services for people who inject drugs: A cluster‐randomized trial
Kathleen R. Page(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Amanda Rosecrans(Johns Hopkins University), Gregory M. Lucas(Johns Hopkins University), Wendy Escobar(Johns Hopkins University), Miles Landry(Johns Hopkins University), Katie Zook(Johns Hopkins University), Suzanne M. Grieb(Johns Hopkins University), Brian W. Weir(Johns Hopkins University), Ronald Saxton(Johns Hopkins University), Susan G. Sherman(Johns Hopkins University), Michael P. Ramirez(Johns Hopkins University), William Clarke(Johns Hopkins University), Robert S. Harris(Johns Hopkins University)
Cited by 8
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
|Annals of the Rheumatic Diseases|2016|275
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers
|Journal of Clinical Microbiology|2020|198
End-Stage Renal Disease Among HIV-Infected Adults in North America
|Clinical Infectious Diseases|2014|172